What is William Blair’s Forecast for APLS Q3 Earnings?
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Stock analysts at William Blair lifted their Q3 2025 earnings estimates for Apellis Pharmaceuticals in a research report issued to clients and investors on Tuesday, April 1st. William Blair analyst L. Hanbury-Brown now anticipates that the company will earn ($0.15) per share for the quarter, up from […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Stock analysts at William Blair lifted their Q3 2025 earnings estimates for Apellis Pharmaceuticals in a research report issued to clients and investors on Tuesday, April 1st. William Blair analyst L. Hanbury-Brown now anticipates that the company will earn ($0.15) per share for the quarter, up from […]
